Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Gene silencing of the p15/INK4B cell-cycle inhibitor by hypermethylation: an early or later epigenetic alteration in myelodysplastic syndromes?

× No keyword cloud information.

12 in total

Review 1. The long arm of long noncoding RNAs: roles as sensors regulating gene transcriptional programs.

Authors: Xiangting Wang; Xiaoyuan Song; Christopher K Glass; Michael G Rosenfeld
Journal: Cold Spring Harb Perspect Biol Date: 2011-01-01 Impact factor: 10.005

2. Downregulation of HO-1 promoted apoptosis induced by decitabine via increasing p15INK4B promoter demethylation in myelodysplastic syndrome.

Authors: D Ma; Q Fang; P Wang; R Gao; J Sun; Y Li; X Y Hu; J S Wang
Journal: Gene Ther Date: 2015-02-05 Impact factor: 5.250

Review 3. DNA methylation as a therapeutic target in hematologic disorders: recent results in older patients with myelodysplasia and acute myeloid leukemia.

Authors: Björn Rüter; Pierre W Wijermans; Michael Lübbert
Journal: Int J Hematol Date: 2004-08 Impact factor: 2.490

Review 4. Epigenetic treatment of myelodysplastic syndromes and acute myeloid leukemias.

Authors: Giuseppe Leone; Francesco D'Alò; Giuseppe Zardo; Maria Teresa Voso; Clara Nervi
Journal: Curr Med Chem Date: 2008 Impact factor: 4.530

Review 5. From bacteria to humans, chromatin to elongation, and activation to repression: The expanding roles of noncoding RNAs in regulating transcription.

Authors: James A Goodrich; Jennifer F Kugel
Journal: Crit Rev Biochem Mol Biol Date: 2009 Jan-Feb Impact factor: 8.250

10. A study on DNA methylation status in promoter region of p15 gene in patients of acute myeloid leukemia and myelodysplastic syndrome.

Authors: Sangeetha Sampath; Pratibha Misra; Sandeep Kumar Yadav; Sanjeevan Sharma; Venkatesan Somasundaram
Journal: Med J Armed Forces India Date: 2021-06-26

Gene silencing of the p15/INK4B cell-cycle inhibitor by hypermethylation: an early or later epigenetic alteration in myelodysplastic syndromes?

Review 1. The long arm of long noncoding RNAs: roles as sensors regulating gene transcriptional programs.

2. Downregulation of HO-1 promoted apoptosis induced by decitabine via increasing p15INK4B promoter demethylation in myelodysplastic syndrome.

Review 3. DNA methylation as a therapeutic target in hematologic disorders: recent results in older patients with myelodysplasia and acute myeloid leukemia.

Review 4. Epigenetic treatment of myelodysplastic syndromes and acute myeloid leukemias.

Review 5. From bacteria to humans, chromatin to elongation, and activation to repression: The expanding roles of noncoding RNAs in regulating transcription.

6. Epigenetic silencing of tumour suppressor gene p15 by its antisense RNA.

7. Development of an oral form of azacytidine: 2'3'5'triacetyl-5-azacytidine.

8. Lenalidomide: a brief review of its therapeutic potential in myelodysplastic syndromes.

Review 9. Realgar (α-As₄S₄) Treats Myelodysplastic Syndromes through Reducing DNA Hypermethylation.

10. A study on DNA methylation status in promoter region of p15 gene in patients of acute myeloid leukemia and myelodysplastic syndrome.

Gene silencing of the p15/INK4B cell-cycle inhibitor by hypermethylation: an early or later epigenetic alteration in myelodysplastic syndromes?

Review 1. The long arm of long noncoding RNAs: roles as sensors regulating gene transcriptional programs.

2. Downregulation of HO-1 promoted apoptosis induced by decitabine via increasing p15INK4B promoter demethylation in myelodysplastic syndrome.

Review 3. DNA methylation as a therapeutic target in hematologic disorders: recent results in older patients with myelodysplasia and acute myeloid leukemia.

Review 4. Epigenetic treatment of myelodysplastic syndromes and acute myeloid leukemias.

Review 5. From bacteria to humans, chromatin to elongation, and activation to repression: The expanding roles of noncoding RNAs in regulating transcription.

6. Epigenetic silencing of tumour suppressor gene p15 by its antisense RNA.

7. Development of an oral form of azacytidine: 2'3'5'triacetyl-5-azacytidine.

8. Lenalidomide: a brief review of its therapeutic potential in myelodysplastic syndromes.

Review 9. Realgar (α-As4S4) Treats Myelodysplastic Syndromes through Reducing DNA Hypermethylation.

10. A study on DNA methylation status in promoter region of p15 gene in patients of acute myeloid leukemia and myelodysplastic syndrome.

Review 9. Realgar (α-As₄S₄) Treats Myelodysplastic Syndromes through Reducing DNA Hypermethylation.